Company Long-Term Loans and Borrowings: enGene Bio (ENGN)
enGene Holdings Inc. (ENGN) attracts leading immunologists by creating non-viral gene delivery systems, leveraging a research-driven approach and stock option programs. However, the lack of revenue due to the clinical trial stage and pending FDA approval keeps margins at 0.03. This price chart reflects the price action of an asset developing safe therapies for bladder cancer and mucosal membrane treatments.
enGene Bio (ENGN) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
- earnings and multiples data:
Analysis of all company metrics:ENGN - engene.com
enGene Holdings Inc. maintains high margins through specialized gene therapy logistics and strict temperature control. Long-term debt analysis measures the aggregate of credit obligations with maturities exceeding one year, determining financial stability and the cost of capital. By examining the firm's history of long-term borrowings, an investor identifies hidden risks between quarterly reports. Reducing this burden directly enhances the business's investment attractiveness.
Competitors of enGene Holdings Inc. (ENGN)
Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|Company Long-Term Liabilities ABCL|Company Long-Term Debts Tourmaline|Company Long-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Long-Term Indebtedness|Company Long-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Long-Term Debt|Zenas Biopharma, Inc. - Company Long-Term Debts|Long-Term Debt Immunome Bio|Gossamer Bio, Inc. (GOSS) - Company Long-Term Debt|Company Long-Term Indebtedness KALV|SEPN (Septerna) - Company Long-Term Debts|PVLA - Long-Term Indebtedness|Company Long-Term Debts SVRA|RIGL - Long-Term Debt|Company Long-Term Debt AnaptysBio, Inc. ANAB|ATXS: Company Long-Term Indebtedness|RAPT Therapeutics, Inc. - Company Long-Term Debts|Long-Term Debt Aerovate Therapeutics Inc|ACRS (Aclaris) - Company Long-Term Liabilities|Kyverna Therapeutics, Inc - Company Long-Term Loans and Borrowings|TLSA (Tiziana Life Sciences) - Company Long-Term Debts|CABA: Company Long-Term Loans and Borrowings|Company Long-Term Debt Ventyx Biosciences, Inc. (VTYX)|THTX - Long-Term Debt|Company Long-Term Debt Avalo Therapeutics Inc. AVTX|Eledon Pharmaceuticals, Inc - Company Long-Term Debt|Agenus - Company Long-Term Debts|CLYM (climbbio.com) - Company Long-Term Indebtedness|ZURA: Company Long-Term Debts|ATYR - Long-Term Debt Volume|Company Long-Term Debt Adagene Inc|Company Long-Term Indebtedness IMA (Ikena Oncology, Inc.)|Company Long-Term Debts STTK|equilliumbio.com (EQ) - Long-Term Indebtedness|Company Long-Term Debt Connect Biopharma Holdings Limited CNTB|Long-Term Debt Volume Immunic Therapeutics (IMUX)|ATRA: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings IFRX (InflaRx N.V.)|XFOR: Company Long-Term Debts|ACET - Long-Term Debt Volume|Company Long-Term Debt Celularity Inc|Company Long-Term Indebtedness INMB (INmune Bio Inc)|Company Long-Term Debts BRNS|Company Long-Term Liabilities Kezar Life Sciences Inc KZR|SAB Biotherapeutics - Company Long-Term Liabilities|Long-Term Debt Volume akaritx.com (AKTX)|Enlivex Therapeutics, Ltd. - Company Long-Term Debts|Long-Term Debt Q32 Bio Inc.|GeoVax Labs Inc (GOVX) - Company Long-Term Debt|Company Long-Term Indebtedness EDSA|IBIO (iBio, Inc.) - Company Long-Term Debts|CARM - Long-Term Indebtedness|Company Long-Term Debt XTL Biopharmaceuticals Ltd. (XTLB)|boltbio.com - Company Long-Term Indebtedness|Company Long-Term Debt HCW Biologics HCWB|APVO (Aptevo Therapeutics, Inc.) - Long-Term Liabilities|AIM ImmunoTech - Company Long-Term Debts|Company Long-Term Loans and Borrowings ADTX (Aditxt)|GRI: Company Long-Term Debts|XORTX Therapeutics Inc (XRTX) - Company Long-Term Debts|Company Long-Term Debt ReShape Lifesciences|REVB: Company Long-Term Loans and Borrowings|Company Long-Term Debt Indaptus Therapeutics (INDP)|Company Long-Term Liabilities scinai.com SCNI|Company Long-Term Debts CALI (CalciMedica)|Company Long-Term Debts Affimed NV AFMD|ALLK: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings HOOK (HOOKIPA Pharma Inc.)|IGMS: Company Long-Term Debts|ITOS - Long-Term Debt Volume|Company Long-Term Debt Ocean Biomedical|Company Long-Term Liabilities TC BioPharm (Holdings) Plc (TCBP)|Company Long-Term Debt Third Harmonic Bio, Inc (THRD)